Clinical Immunology, Neuropharmacology and Drug Development

Blood-Brain Barrier: Challenges and Solutions

This track addresses the critical challenges associated with the blood-brain barrier (BBB) in drug development for neurological diseases. Researchers are invited to submit abstracts on strategies to enhance drug delivery across the BBB, including the use of nanotechnology, focused ultrasound, and molecular transporters. The track will also explore the physiological mechanisms that regulate the BBB and how these can be modulated to improve therapeutic efficacy. Attendees will gain a comprehensive understanding of the latest innovations aimed at overcoming one of the most significant barriers in neuropharmacology.